189 related articles for article (PubMed ID: 2922627)
1. Methemoglobinemia and hemolytic anemia after phenazopyridine hydrochloride (Pyridium) administration in end-stage renal disease.
Fincher ME; Campbell HT
South Med J; 1989 Mar; 82(3):372-4. PubMed ID: 2922627
[TBL] [Abstract][Full Text] [Related]
2. Acquired methemoglobinemia and hemolytic anemia after usual doses of phenazopyridine.
Jeffery WH; Zelicoff AP; Hardy WR
Drug Intell Clin Pharm; 1982 Feb; 16(2):157-9. PubMed ID: 7075467
[TBL] [Abstract][Full Text] [Related]
3. Acquired methemoglobinemia and hemolytic anemia following excessive pyridium (phenazopyridine hydrochloride) ingestion.
Cohen BL; Bovasso GJ
Clin Pediatr (Phila); 1971 Sep; 10(9):537-40. PubMed ID: 5095165
[No Abstract] [Full Text] [Related]
4. Acute methemoglobinemia and hemolytic anemia with phenazopyridine: possible relation to acute renal failure.
Nathan DM; Siegel AJ; Bunn HF
Arch Intern Med; 1977 Nov; 137(11):1636-8. PubMed ID: 921457
[TBL] [Abstract][Full Text] [Related]
5. Phenazopyridine hydrochloride toxicity: a cause of drug-induced methemoglobinemia.
Green ED; Zimmerman RC; Ghurabi WH; Colohan DP
JACEP; 1979 Oct; 8(10):426-31. PubMed ID: 385954
[No Abstract] [Full Text] [Related]
6. Phenazopyridine-induced hemolytic anemia.
Noonan HM; Kimbrell M; Johnson WB; Reuler JB
Urology; 1983 Jun; 21(6):623-4. PubMed ID: 6868236
[TBL] [Abstract][Full Text] [Related]
7. Phenazopyridine (Pyridium) poisoning: possible toxicity of methylene blue administration in renal failure.
Sharon M; Puente G; Cohen LB
Mt Sinai J Med; 1986 Apr; 53(4):280-2. PubMed ID: 3487723
[No Abstract] [Full Text] [Related]
8. Methemoglobinemia from overdose of phenazopyridine hydrochloride.
Zimmerman RC; Green ED; Ghurabi WH; Colohan DP
Ann Emerg Med; 1980 Mar; 9(3):147-9. PubMed ID: 7362105
[TBL] [Abstract][Full Text] [Related]
9. Methaemoglobinaemia produced by phenazopyridine (Pyridium) in a man with chronic obstructive airways disease.
Chakraborty TK; Filshie RJ; Lee MR
Scott Med J; 1987 Dec; 32(6):185-6. PubMed ID: 3449947
[TBL] [Abstract][Full Text] [Related]
10. [Sedural toxicity].
Kornowski R; Averbuch M; Jaffe A; Schwartz D; Levo Y
Harefuah; 1991 Mar; 120(6):324-5. PubMed ID: 1879765
[TBL] [Abstract][Full Text] [Related]
11. Acute hemolytic anaemia due to phenazopyridine hydrochloride in G-6-PD deficient subject.
Mercieca JE; Clarke MF; Phillips ME; Curtis JR
Lancet; 1982 Sep; 2(8297):564. PubMed ID: 6125724
[No Abstract] [Full Text] [Related]
12. [Cyanosis as a result of drug-induced methemoglobinemia. A case report].
Hess W; Eberlein HJ; Pöthe H
Anaesthesist; 1983 Mar; 32(3):124-6. PubMed ID: 6859496
[TBL] [Abstract][Full Text] [Related]
13. Phenazopyridine-induced hemolytic anemia in a patient with G6PD deficiency.
Tishler M; Abramov A
Acta Haematol; 1983; 70(3):208-9. PubMed ID: 6410650
[No Abstract] [Full Text] [Related]
14. Phenazopyridine-induced hemolytic anemia in G-6-PD deficiency.
Galun E; Oren R; Glikson M; Friedlander M; Heyman A
Drug Intell Clin Pharm; 1987 Nov; 21(11):921-2. PubMed ID: 3678069
[No Abstract] [Full Text] [Related]
15. Phenazopyridine-induced methemoglobinemia.
Terrell JR; Spruill WJ; Parish RC; Jenkins FH
Drug Intell Clin Pharm; 1988 Nov; 22(11):915. PubMed ID: 3234262
[No Abstract] [Full Text] [Related]
16. Heinz-body hemolytic anemia associated with phenazopyridine and sulfonamide.
Ponte CD; Lewis MJ; Rogers JS
DICP; 1989 Feb; 23(2):140-2. PubMed ID: 2786291
[TBL] [Abstract][Full Text] [Related]
17. Methemoglobinemia, muscle damage and renal failure complicating phenazopyridine overdose.
Gavish D; Knobler H; Gottehrer N; Israeli A; Kleinman Y
Isr J Med Sci; 1986 Jan; 22(1):45-7. PubMed ID: 3957643
[TBL] [Abstract][Full Text] [Related]
18. Hemolytic anemia after methylene blue therapy for aniline-induced methemoglobinemia.
Liao YP; Hung DZ; Yang DY
Vet Hum Toxicol; 2002 Feb; 44(1):19-21. PubMed ID: 11824767
[TBL] [Abstract][Full Text] [Related]
19. Skin ulcers as a complication of short-term use of phenazopyridine in an old man: A case report.
Zarei B; Tavanaee Sani A; Elyasi S
J Infect Chemother; 2022 Dec; 28(12):1654-1657. PubMed ID: 35963601
[TBL] [Abstract][Full Text] [Related]
20. Inadequacy of information of side effects.
Bateman CJ
Br Med J; 1978 Dec; 2(6153):1716. PubMed ID: 737460
[No Abstract] [Full Text] [Related]
[Next] [New Search]
